FDA — authorised 17 December 1990
- Marketing authorisation holder: RANBAXY
- Status: approved
🇺🇸 Ultravate in United States
FDA authorised Ultravate on 17 December 1990
Marketing authorisations
FDA — authorised 27 December 1990
- Application: NDA019967
- Marketing authorisation holder: SUN PHARM INDS INC
- Local brand name: ULTRAVATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 6 November 2015
- Application: NDA208183
- Marketing authorisation holder: LACER PHARMA
- Local brand name: ULTRAVATE
- Indication: LOTION — TOPICAL
- Status: approved
Ultravate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Ultravate approved in United States?
Yes. FDA authorised it on 17 December 1990; FDA authorised it on 27 December 1990; FDA authorised it on 6 November 2015.
Who is the marketing authorisation holder for Ultravate in United States?
RANBAXY holds the US marketing authorisation.